Growth Metrics

Fulgent Genetics (FLGT) Shares Outstanding (Weighted Average) (2016 - 2026)

Fulgent Genetics' Shares Outstanding (Weighted Average) history spans 12 years, with the latest figure at $30.9 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.16% to $30.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $30.9 million, a 0.16% change, with the full-year FY2025 number at $30.8 million, up 1.79% from a year prior.
  • Shares Outstanding (Weighted Average) hit $30.9 million in Q1 2026 for Fulgent Genetics, roughly flat from $30.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for FLGT hit a ceiling of $30.9 million in Q1 2026 and a floor of $29.5 million in Q1 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $30.3 million across 5 years, with a median of $30.2 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 4.87% in 2022 and later decreased 2.31% in 2023.
  • Tracing FLGT's Shares Outstanding (Weighted Average) over 5 years: stood at $30.1 million in 2022, then fell by 1.04% to $29.8 million in 2023, then grew by 1.51% to $30.2 million in 2024, then grew by 1.79% to $30.8 million in 2025, then increased by 0.34% to $30.9 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for FLGT at $30.9 million in Q1 2026, $30.8 million in Q4 2025, and $30.7 million in Q3 2025.